Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
Failure to detect early-stage epithelial ovarian cancer (EOC) is a major contributing factor to its low survival rate. Increasing evidence suggests that different subtypes of EOC may behave as distinct diseases due to their different cells of origins, histology and treatment responses. Therefore, th...
Main Authors: | Meng-Shin Shiao, Jia-Ming Chang, Arb-Aroon Lertkhachonsuk, Naparat Rermluk, Natini Jinawath |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/10/1433 |
Similar Items
-
Role of Circulating miRNAs in Therapeutic Response in Epithelial Ovarian Cancer: A Systematic Revision
by: Gloria Ravegnini, et al.
Published: (2021-09-01) -
Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer
by: Jun Xiong, et al.
Published: (2023-05-01) -
Exosomal microRNAs as tumor markers in epithelial ovarian cancer
by: Chi Pan, et al.
Published: (2018-11-01) -
Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer
by: Shiwen Wang, et al.
Published: (2022-12-01) -
Editorial: Exosomes and exosomal miRNAs as biomarkers in infection with Mycobacterium tuberculosis
by: Shamila D. Alipoor
Published: (2023-07-01)